Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Hadassah Medical Center, Bellvitge University Hospital, Universitat de Barcelona, Pirogov Russian National Research Medical University, St. Josef-Hospital, University of Pecs, Medical University of Lodz, Sheffield Teaching Hospitals NHS Foundation Trust
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2168423102
